MoneyWorks4Me

Sequent Scientific - Quaterly Results

08 Aug 2025 Evaluate
The sales slipped to Rs. 410.70 millions for the June 2025 quarter as against Rs. 576.70 millions during the year-ago period.Net profit declined -25.11% to Rs. 33.70 millions from Rs. 45.00 millions.The company reported a good operating profit of 94.40 millions compared to 88.60 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 410.70 576.70 -28.78 410.70 576.70 -28.78 1782.60 1685.20 5.78
Other Income 114.80 108.40 5.90 114.80 108.40 5.90 509.40 459.80 10.79
PBIDT 94.40 88.60 6.55 94.40 88.60 6.55 395.60 193.20 104.76
Interest 10.80 8.10 33.33 10.80 8.10 33.33 39.60 43.60 -9.17
PBDT 71.10 80.50 -11.68 71.10 80.50 -11.68 307.20 87.10 252.70
Depreciation 23.30 20.00 16.50 23.30 20.00 16.50 86.70 89.40 -3.02
PBT 47.80 60.50 -20.99 47.80 60.50 -20.99 220.50 -2.30 -9686.96
TAX 14.10 15.50 -9.03 14.10 15.50 -9.03 62.50 -8.60 -826.74
Deferred Tax 5.70 5.80 -1.72 5.70 5.80 -1.72 23.70 -13.20 -279.55
PAT 33.70 45.00 -25.11 33.70 45.00 -25.11 158.00 6.30 2407.94
Equity 500.70 499.00 0.34 500.70 499.00 0.34 500.60 498.90 0.34
PBIDTM(%) 22.99 15.36 49.61 22.99 15.36 49.61 22.19 11.46 93.57
Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1210.50
Cipla 1369.10
Lupin 2120.00
Zydus Lifesciences 1167.25
View more..